Key facts
- Notable investors include Lazio Innova, University of Rome Tor Vergata.
- Status: Acquired/Merged (Operating Subsidiary).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Cryolab
- ·The full record, as it builds
Funding rounds
No funding rounds for Cryolab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cryolab
Operator of a biotechnology and cryobiology development center intended for clinical, public, and private research institutions. The company offers the progress of medical research and scientific discoveries, standardizing the advanced methods for material sampling, processing, and storage of biological samples.
- Sector
- Healthcare
- HQ
- Rome, Italy
- Founded
- 2012
- Employees
- 9
- Website
- cryolab.it/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Cryolab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cryolab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cryolab in its N-PORT filings yet. We sweep new filings monthly.